Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Armored CAR T-Cells: The Next Chapter in T-Cell Cancer Immunotherapy
Elizabeth Hawkins, Reena R. D’Souza, Astero Klampatsa
Biologics (2021) Vol. Volume 15, pp. 95-105
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

Lung cancer immunotherapy: progress, pitfalls, and promises
Aritraa Lahiri, Avik Maji, Pravin D. Potdar, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 476
Cancer treatments: Past, present, and future
Dmitriy Sonkin, Anish Thomas, Beverly A. Teicher
Cancer Genetics (2024) Vol. 286-287, pp. 18-24
Open Access | Times Cited: 62
Chimeric antigen receptor T cell therapy for autoimmune disease
James B. Chung, Jennifer N. Brudno, Dominic Borie, et al.
Nature reviews. Immunology (2024)
Closed Access | Times Cited: 25
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Lei Peng, Giacomo Sferruzza, Luojia Yang, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 10, pp. 1089-1108
Open Access | Times Cited: 18
Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies
Yan-Ruide Li, Tyler Halladay, Lili Yang
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 17
CAR-T cell expansion platforms yield distinct T cell differentiation states
Hannah Song, Michaela Procházková, Lipei Shao, et al.
Cytotherapy (2024) Vol. 26, Iss. 7, pp. 757-768
Open Access | Times Cited: 13
Fibroblast Activation Protein (FAP)-Targeted CAR-T Cells: Launching an Attack on Tumor Stroma
Reyisa Bughda, Paraskevi Dimou, Reena R. D’Souza, et al.
ImmunoTargets and Therapy (2021) Vol. Volume 10, pp. 313-323
Open Access | Times Cited: 97
Improving CAR T-Cell Persistence
Violena Pietrobon, Lauren A. Todd, Anghsumala Goswami, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10828-10828
Open Access | Times Cited: 70
Intratumoral pan-ErbB targeted CAR-T for head and neck squamous cell carcinoma: interim analysis of the T4 immunotherapy study
Sophie Papa, Antonella Adami, Michael Metoudi, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 6, pp. e007162-e007162
Open Access | Times Cited: 23
Gamma/delta T cells as cellular vehicles for anti-tumor immunity
Chelsia Qiuxia Wang, Pei Yu Lim, Andy Hee‐Meng Tan
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 10
Challenges and strategies associated with CAR-T cell therapy in blood malignancies
Zhaoyun Liu, Wenhui Lei, Hao Wang, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Understanding CAR T cell-tumor interactions: Paving the way for successful clinical outcomes
Felix Korell, Trisha R. Berger, Marcela V. Maus
Med (2022) Vol. 3, Iss. 8, pp. 538-564
Open Access | Times Cited: 32
Tumor Microenvironment Immunosuppression: A Roadblock to CAR T-Cell Advancement in Solid Tumors
Abigail Cheever, Michelle H. Townsend, Kim L. O’Neill
Cells (2022) Vol. 11, Iss. 22, pp. 3626-3626
Open Access | Times Cited: 29
Role of CAR T Cell Metabolism for Therapeutic Efficacy
Judit Rial Saborido, Simon Völkl, Michael Aigner, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5442-5442
Open Access | Times Cited: 27
Challenges and solutions for therapeuticTCR‐based agents
Manish Malviya, Zita E. H. Aretz, Zaki Molvi, et al.
Immunological Reviews (2023) Vol. 320, Iss. 1, pp. 58-82
Closed Access | Times Cited: 16
Chimeric Antigen Receptor T Cells in Glioblastoma—Current Concepts and Promising Future
Rebecca Kringel, Katrin Lamszus, Malte Mohme
Cells (2023) Vol. 12, Iss. 13, pp. 1770-1770
Open Access | Times Cited: 15
A CAR enhancer increases the activity and persistence of CAR T cells
Taha Rakhshandehroo, Shreya R. Mantri, Seyed Heydar Moravej, et al.
Nature Biotechnology (2024)
Closed Access | Times Cited: 6
Alternative target recognition elements for chimeric antigen receptor (CAR) T cells: beyond standard antibody fragments
Matthew A. Nix, Arun P. Wiita
Cytotherapy (2024) Vol. 26, Iss. 7, pp. 729-738
Open Access | Times Cited: 5
Glioblastoma Vaccines as Promising Immune-Therapeutics: Challenges and Current Status
Asmae Squalli Houssaini, Salma Lamrabet, Jean Paul Nshizirungu, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 655-655
Open Access | Times Cited: 5
Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy
X. Xia, Zongxin Yang, Qisi Lu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Therapeutic potential of anti-ErbB3 chimeric antigen receptor natural killer cells against breast cancer
J.H. Lee, Jinhoo Song, Wonbeak Yoo, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 2
Open Access
CAR-T Cell Therapy for Solid Tumors
Liz T. Tony, Andrea Stabile, Marc Philipp Schauer, et al.
Transfusion Medicine and Hemotherapy (2025), pp. 1-13
Open Access
Orthogonalized human protease control of secreted signals
Carlos A. Aldrete, Connor C. Call, Lucas E. Sant’Anna, et al.
Nature Chemical Biology (2025)
Open Access
Revolutionizing pancreatic cancer treatment with CAR-T therapy
Kirti Baghel, Sanjana Mehrotra, Vijay Prajapati
Advances in protein chemistry and structural biology (2025), pp. 331-353
Closed Access
Multifunctional polymeric micelle-based nucleic acid delivery: Current advances and future perspectives
Ivana Jarak, Miguel Pereira‐Silva, Ana Cláudia Paiva‐Santos, et al.
Applied Materials Today (2021) Vol. 25, pp. 101217-101217
Closed Access | Times Cited: 34
Page 1 - Next Page

Scroll to top